The teleNIDA: Early Screening of Autism Spectrum Disorder through a Novel Telehealth Approach

Saved in:
Bibliographic Details
Title: The teleNIDA: Early Screening of Autism Spectrum Disorder through a Novel Telehealth Approach
Language: English
Authors: Valentina Riva, Laura Villa, Francesca Fulceri, Giuseppe Maurizio Arduino, Guido Leonti, Giovanni Valeri, Laura Casula, Leonardo Zoccante, Elena Puttini, Carla Sogos, Mariaelena Presicce, Arianna Bentenuto, Fabio Apicella, Massimo Molteni, Maria Luisa Scattoni (ORCID 0000-0002-6659-0280)
Source: Journal of Autism and Developmental Disorders. 2024 54(5):1680-1690.
Availability: Springer. Available from: Springer Nature. One New York Plaza, Suite 4600, New York, NY 10004. Tel: 800-777-4643; Tel: 212-460-1500; Fax: 212-460-1700; e-mail: customerservice@springernature.com; Web site: https://link.springer.com/
Peer Reviewed: Y
Page Count: 11
Publication Date: 2024
Document Type: Journal Articles
Reports - Research
Descriptors: Screening Tests, Early Intervention, Telecommunications, Autism Spectrum Disorders, COVID-19, Pandemics, Children, Psychometrics, Toddlers, Health Services
DOI: 10.1007/s10803-023-05927-6
ISSN: 0162-3257
1573-3432
Abstract: The COVID-19 pandemic has fast-tracked interest in telehealth methods to guarantee the continuity of care of children with Autism Spectrum Disorder (ASD). Store-and-forward telehealth approaches offer the opportunity to facilitate timely screening of ASD, allowing parents to record videos of their child's behaviors, subsequently shared with clinicians that provide an assessment remotely. This study aimed to examine the psychometric properties of a new telehealth screening tool, the teleNIDA, administered in home settings for remote observation of early signs of ASD in toddlers aged 18--30 months. Results showed good psychometric properties of the teleNIDA, as compared to the gold standard in-person assessment, and the predictive validity on the diagnosis of ASD at 36 months was demonstrated. This study supports the teleNIDA as a promising level 2 screening tool for ASD able to speed up diagnostic and intervention processes.
Abstractor: As Provided
Entry Date: 2024
Accession Number: EJ1426109
Database: ERIC
Full text is not displayed to guests.
Description
Abstract:The COVID-19 pandemic has fast-tracked interest in telehealth methods to guarantee the continuity of care of children with Autism Spectrum Disorder (ASD). Store-and-forward telehealth approaches offer the opportunity to facilitate timely screening of ASD, allowing parents to record videos of their child's behaviors, subsequently shared with clinicians that provide an assessment remotely. This study aimed to examine the psychometric properties of a new telehealth screening tool, the teleNIDA, administered in home settings for remote observation of early signs of ASD in toddlers aged 18--30 months. Results showed good psychometric properties of the teleNIDA, as compared to the gold standard in-person assessment, and the predictive validity on the diagnosis of ASD at 36 months was demonstrated. This study supports the teleNIDA as a promising level 2 screening tool for ASD able to speed up diagnostic and intervention processes.
ISSN:0162-3257
1573-3432
DOI:10.1007/s10803-023-05927-6